Yield10 Bioscience Inc (NASDAQ:YTEN) Short Interest Update

Yield10 Bioscience Inc (NASDAQ:YTEN) was the recipient of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 44,400 shares, a decrease of 22.2% from the August 15th total of 57,100 shares. Approximately 2.4% of the shares of the company are short sold. Based on an average daily trading volume, of 1,240,000 shares, the days-to-cover ratio is presently 0.0 days.

Shares of NASDAQ YTEN opened at $7.25 on Thursday. The company has a market capitalization of $20.43 million, a price-to-earnings ratio of -0.34 and a beta of 2.55. The company has a debt-to-equity ratio of 0.40, a current ratio of 6.15 and a quick ratio of 6.15. The business has a 50-day moving average of $5.59 and a two-hundred day moving average of $5.57. Yield10 Bioscience has a 1 year low of $3.50 and a 1 year high of $31.05.

Yield10 Bioscience (NASDAQ:YTEN) last announced its quarterly earnings results on Tuesday, August 11th. The specialty chemicals company reported ($0.92) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($1.30) by $0.38. Yield10 Bioscience had a negative return on equity of 347.89% and a negative net margin of 1,861.39%. As a group, equities research analysts expect that Yield10 Bioscience will post -4.78 earnings per share for the current year.

A number of analysts have recently commented on YTEN shares. Maxim Group restated a “buy” rating and issued a $12.00 target price on shares of Yield10 Bioscience in a research note on Thursday, August 13th. National Securities upgraded Yield10 Bioscience from a “neutral” rating to a “buy” rating and set a $15.00 price target on the stock in a research report on Thursday, August 27th. Zacks Investment Research downgraded Yield10 Bioscience from a “buy” rating to a “hold” rating in a research report on Friday, September 4th. Finally, HC Wainwright began coverage on Yield10 Bioscience in a research report on Thursday, September 10th. They set a “buy” rating and a $25.00 price target on the stock.

A hedge fund recently bought a new stake in Yield10 Bioscience stock. Virtu Financial LLC bought a new position in shares of Yield10 Bioscience Inc (NASDAQ:YTEN) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 10,246 shares of the specialty chemicals company’s stock, valued at approximately $64,000. Virtu Financial LLC owned 0.52% of Yield10 Bioscience at the end of the most recent quarter. 6.08% of the stock is currently owned by hedge funds and other institutional investors.

Yield10 Bioscience Company Profile

Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.

Read More: Market Indexes

Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.